JP Morgan Raises PT Of Humana To $63.00 (HUM)

JP Morgan raises the Price Target to $63 from $61 after Humana HUM posted Q4 EPS of “$0.63 vs our/consensus $0.69/0.78.” The report notes, “much like others this season so far, the report benefited from moderate med utilization offset by a heavy dose of cleanup/one-time items (about $1/share) which held down the reported EPS. With this follow-up note to our detailed report yesterday, we are updating our '11 and '12 EPS estimates, raising each by $0.20, to $6.20 and $6.00 respectively.” JP Morgan raises the Price Target to $63 and maintains its Neutral rating. Humana is currently trading unchanged in the premarket from Tuesday's close of $58.31.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareHumanaJP MorganManaged Health Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!